Market Snapshot

BSE Sensex: 77763.91 0.34%
BSE 500: 36431.45 0.15%
BSE 200: 11317.86 0.17%
BSE 100: 25809.44 0.24%
BSE BANKEX: 65450.3 -0.09%
BSE IT: 26730.46 1.55%
Nifty 50: 24270.85 0.39%
Nifty 500: 23301.15 0.16%
Nifty 200: 13992.05 0.19%
Nifty 100: 25301.9 0.28%
Nifty Midcap 100: 62190.3 -0.19%
Nifty Small 100: 19175.1 0.04%
Nifty IT: 27439.4 1.76%
Nifty PSU Bank: 8407.6 -1.54%

News:

Karur Vysya Banks total busine...
Yes Bank reports 18% YoY rise ...
Godrej Consumer Products expec...
Quality Power arm Mehru Electr...
Bandhan Banks total deposits r...

Balaxi Pharmaceuticals Ltd Share Price – NSE
Pharmaceuticals, Small Cap

Invest

03 Jul 2026 | 04:14 PM

23.67

-0.46 (-1.91%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-51.57%

Return (1Y)

Underperformed Nifty 50 by 47.1%
More Volatile

3.05%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.23%
Inconsistent Performer

1/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

52

15

News & Announcements

Balaxi Pharmaceuticals to conduct AGM
34 days ago

Balaxi Pharmaceuticals to conduct AGM

01 - Jun - 2026 12:00 | 34 days ago

Balaxi Pharmaceuticals announced that the 83th Annual General Meeting(AGM) of the company will be held on 24 August 2026.

Balaxi Pharmaceuticals consolidated net profit declines 92.94% in the March 2026 quarter

37 days ago

Balaxi Pharmaceuticals to hold board meeting
55 days ago

Balaxi Pharmaceuticals to hold board meeting

11 - May - 2026 12:00 | 55 days ago

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 May 2026.
Balaxi Pharmaceuticals consolidated net profit declines 94.22% in the December 2025 quarter
153 days ago

Balaxi Pharmaceuticals consolidated net profit declines 94.22% in the December 2025 quarter

02 - Feb - 2026 12:00 | 153 days ago

Net profit of Balaxi Pharmaceuticals declined 94.22% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 5.36 crore during the previous quarter ended December 2024. Sales declined 1.02% to Rs 72.54 crore in the quarter ended December 2025 as against Rs 73.29 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 72.54 73.29 -1

OPM % 4.26 5.44 -

PBDT 2.17 6.55 -67

PBT 1.61 6.07 -73

NP 0.31 5.36 -94

Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in Balaxi Pharmaceuticals Ltd has decreased by -100% since past 3 Months
FII shareholding in Balaxi Pharmaceuticals Ltd has decreased by -100% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60